van der Horst, Geertje <br/><br/>
Targeting of alpha-v integrins reduces malignancy of bladder carcinoma.  [electronic resource] 

 -  PloS one  2014 
 - e108464 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1932-6203 
<br/><br/><label>Standard No.: </label>10.1371/journal.pone.0108464  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aldehyde Dehydrogenase--biosynthesis<br/>Animals<br/>Carcinoma, Transitional Cell--pathology<br/>Cell Adhesion--drug effects<br/>Cell Line, Tumor<br/>Cell Movement--drug effects<br/>Cell Self Renewal--drug effects<br/>Epithelial-Mesenchymal Transition--drug effects<br/>Female<br/>Gene Expression Regulation, Neoplastic--drug effects<br/>Genetic Vectors--pharmacology<br/>Heart<br/>Humans<br/>Integrin alphaV--drug effects<br/>Mice<br/>Mice, Inbred BALB C<br/>Mice, Nude<br/>Molecular Targeted Therapy<br/>Neoplasm Invasiveness<br/>Neoplasm Proteins--antagonists & inhibitors<br/>Neoplasm Transplantation--methods<br/>Papilloma--pathology<br/>RNA Interference<br/>RNA, Small Interfering--pharmacology<br/>Receptors, Vitronectin--antagonists & inhibitors<br/>Tibia<br/>Transcription Factors--biosynthesis<br/>Transduction, Genetic<br/>Tumor Stem Cell Assay<br/>Urinary Bladder Neoplasms--pathology<br/>Xenograft Model Antitumor Assays